# Daiichi Sankyo Europe GmbH, Pfaffenhofen A.D.Ilm, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6

> Inspection records and compliance data for Daiichi Sankyo Europe GmbH in Pfaffenhofen A.D.Ilm. 6 FDA inspections on record, 1 Form 483, last inspected July 18, 2025.

---

## Details

- Name: Daiichi Sankyo Europe GmbH
- FEI Number: 3003282622
- Address Line 1: Luitpoldstr. 1
- City: Pfaffenhofen A.D.Ilm
- Country Name: Germany
- Address: Luitpoldstr. 1, Pfaffenhofen A.D.Ilm, Germany
- Country: Germany

## Related Documents

- [483 - Daiichi Sankyo Europe GmbH - 2025-07-18](https://www.keypedia.com/records/483/daiichi-sankyo-europe-gmbh/5f48dc36-8c0c-4493-a634-ec2288eadad6) — source: FDA, date: July 18, 2025
- [FDA Inspection 1275919 - Daiichi Sankyo Europe GmbH - 2025-07-18](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/02cc4ef0-7e2f-4314-a0e8-7193ad8f6f8f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2025
- FDA Inspection 1073797 - Daiichi Sankyo Europe GmbH - 2018-10-19 — classification: No Action Indicated (NAI), source: FDA, date: October 19, 2018
- FDA Inspection 1019118 - Daiichi Sankyo Europe GmbH - 2017-06-09 — source: FDA, date: June 9, 2017
- FDA Inspection 882156 - Daiichi Sankyo Europe GmbH - 2014-05-15 — classification: No Action Indicated (NAI), source: FDA, date: May 15, 2014
- FDA Inspection 802508 - Daiichi Sankyo Europe GmbH - 2012-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2012
- FDA Inspection 649526 - Daiichi Sankyo Europe GmbH - 2010-01-29 — classification: No Action Indicated (NAI), source: FDA, date: January 29, 2010

## Related Companies

- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/92dc52fe-a8d7-4a23-bc34-be68892d8866)
- [Mylan Laboratories Limited (FDF-2)](https://www.keypedia.com/companies/mylan-laboratories-limited-fdf-2/1bcb64f5-f3f2-412e-81da-b3efab26f310)
- [Senador Laboratories Private Limited](https://www.keypedia.com/companies/senador-laboratories-private-limited/07781b9f-6d88-4334-96e4-438175fbaf9d)
- [Mipharm S.p.A.](https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc)
- [Nostrum Laboratories, Inc.](https://www.keypedia.com/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Cosette Pharmaceuticals NC Laboratories, LLC](https://www.keypedia.com/companies/cosette-pharmaceuticals-nc-laboratories-llc/4f90e360-99ea-4457-a022-4950a8ea7644)
- [Eisai, Inc.](https://www.keypedia.com/companies/eisai-inc/1e0d6af4-f962-4ac0-826f-90ce5f71a0a3)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)
- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)

## Related Officers

- [Joseph A. Piechocki](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)